Bruker Corporation to Acquire PhenomeX Inc for $108 Million

Bruker Corporation Acquires NanoString Technologies Business

May 6, 2024

Medical Devices

Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.

Bruker Corporation Acquires Canopy Biosciences, LLC

September 11, 2020

Biotechnology

Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.

Bruker Corporation to Acquire Neurescence Inc.

November 12, 2022

Healthcare Services

Bruker Corporation has signed a definitive agreement to purchase 100% of the shares of Neurescence Inc., an ultralight fiber-bundle Multiscopes provider for simultaneous multi-region optical functional neuroimaging. The acquisition is expected to create synergies with Bruker’s multiphoton and head-mounted miniscope offerings, expanding its reach in freely behaving animal imaging and photostimulation.

Merck to Acquire Acceleron Pharma Inc for $11.5B

September 30, 2021

Biotechnology

Merck (through a subsidiary) entered into a definitive agreement to acquire Acceleron Pharma Inc for $180 per share in cash, for an approximate total equity value of $11.5 billion. The transaction will be completed via a tender offer followed by a merger, and is expected to close in the fourth quarter of 2021, subject to conditions including regulatory approvals and tender of at least a majority of outstanding shares.

AmerisourceBergen Acquires PharmaLex for €1.28B

December 31, 2022

Healthcare Services

AmerisourceBergen Corporation signed a definitive agreement to acquire PharmaLex Holding GmbH, a Germany-headquartered provider of specialized life-sciences services, for €1.28 billion in cash. The deal is positioned to expand AmerisourceBergen’s global biopharma services platform across the pharmaceutical development and commercialization journey. The transaction ultimately closed at year-end 2022.

Bruker Acquires Dynamic Biosensors GmbH

October 2, 2024

Biotechnology

Bruker Corporation has acquired Dynamic Biosensors GmbH, a Munich-based developer of single-cell interaction cytometry and biosensor instruments, to strengthen Bruker’s biosensors portfolio. The deal combines Dynamic Biosensors’ heliXcyto and heliX+ technologies with Bruker’s high-throughput SPR systems to expand capabilities and product offerings for drug discovery and biopharma research; financial terms were not disclosed.